Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Assets (2020 - 2025)

Rapid Micro Biosystems' Assets history spans 6 years, with the latest figure at $74.9 million for Q4 2025.

  • On a quarterly basis, Assets fell 23.75% to $74.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $74.9 million, a 23.75% decrease, with the full-year FY2025 number at $74.9 million, down 23.75% from a year prior.
  • Assets hit $74.9 million in Q4 2025 for Rapid Micro Biosystems, down from $84.4 million in the prior quarter.
  • Over the last five years, Assets for RPID hit a ceiling of $254.4 million in Q3 2021 and a floor of $74.9 million in Q4 2025.
  • Historically, Assets has averaged $150.6 million across 5 years, with a median of $143.5 million in 2023.
  • Biggest five-year swings in Assets: surged 244.54% in 2021 and later crashed 35.44% in 2025.
  • Tracing RPID's Assets over 5 years: stood at $241.2 million in 2021, then decreased by 20.95% to $190.6 million in 2022, then decreased by 24.76% to $143.5 million in 2023, then crashed by 31.57% to $98.2 million in 2024, then fell by 23.75% to $74.9 million in 2025.
  • Business Quant data shows Assets for RPID at $74.9 million in Q4 2025, $84.4 million in Q3 2025, and $75.6 million in Q2 2025.